{"disease":{"id":"hematologic-neoplasm","name":"hematologic neoplasm"},"drugs":{"marketed":[{"drug_id":"part-c-met097","indication_name":"Treatment of Mastocytosis with an Associated Hematological Neoplasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(Part C) MET097","generic_name":"part-c-met097","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":37,"revenue":null,"mechanism":"The exact mechanism of action is not specified on Wikipedia."},{"drug_id":"part-c-met097","indication_name":"Treatment of Mastocytosis with an Associated Non-Hematological Neoplasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(Part C) MET097","generic_name":"part-c-met097","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":37,"revenue":null,"mechanism":"The exact mechanism of action is not specified on Wikipedia."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00071045","title":"Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04871165","title":"Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals","phase":"","overall_status":"UNKNOWN","enrollment_count":3270,"lead_sponsor_name":"Vilnius University","has_results":false},{"nct_id":"NCT02958462","title":"Pre-myeloid Cancer and Bone Marrow Failure Clinic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03844360","title":"Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Wei Zhao","has_results":false},{"nct_id":"NCT03301493","title":"Genomic Testing and Resulting Medical Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Arbeitsgemeinschaft medikamentoese Tumortherapie","has_results":false},{"nct_id":"NCT05502887","title":"The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Prof. Dr. Thomas Luft","has_results":false},{"nct_id":"NCT03505086","title":"Bleeding In Thrombocytopenia Explained","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research","has_results":false},{"nct_id":"NCT05819762","title":"Evaluation of ClearLLab LS Screening Panel","phase":"","overall_status":"COMPLETED","enrollment_count":831,"lead_sponsor_name":"Beckman Coulter, Inc.","has_results":false},{"nct_id":"NCT04264767","title":"Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Nucleix Ltd.","has_results":false},{"nct_id":"NCT03207854","title":"Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05054231","title":"Immunological Profile for Patients Treated With CAR-T Cells","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT03222258","title":"Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05327023","title":"Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":430,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03083327","title":"Prophylactic Early PN in HPT/BMT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":408,"lead_sponsor_name":"University of Sydney","has_results":false},{"nct_id":"NCT07085065","title":"Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies","phase":"NA","overall_status":"RECRUITING","enrollment_count":365,"lead_sponsor_name":"Yesmine Amara","has_results":false},{"nct_id":"NCT01915498","title":"Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT02158858","title":"A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Constellation Pharmaceuticals","has_results":false},{"nct_id":"NCT04959175","title":"Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04695431","title":"Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM","phase":"","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT05882175","title":"Prospective Validation of the OHI Index","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT03288441","title":"Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT03219268","title":"A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"MacroGenics","has_results":false},{"nct_id":"NCT06339541","title":"The ACC Preclinical Research Platform for Precision Oncology","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT06433349","title":"A Multi-center Investigation of Family Health.","phase":"","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT03349372","title":"Impact of Pulmonary Follow-up After Stem Cell Graft","phase":"","overall_status":"COMPLETED","enrollment_count":227,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06422533","title":"Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":226,"lead_sponsor_name":"Instituto Nacional de Cancerologia de Mexico","has_results":false},{"nct_id":"NCT05058339","title":"Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":223,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05672420","title":"Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":181,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT07162038","title":"Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":155,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03246906","title":"Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":150,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT07519811","title":"LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT02329847","title":"A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT03483194","title":"Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Weprom","has_results":false},{"nct_id":"NCT03087227","title":"Shared Health Information System for Febrile Neutropenia","phase":"NA","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Marie-Helene METZGER","has_results":false},{"nct_id":"NCT03908138","title":"RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Shandong Provincial Hospital","has_results":false},{"nct_id":"NCT04572815","title":"Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":116,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT05602051","title":"Mindfulness-based Virtual Reality Intervention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Nanjing University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03648372","title":"A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":109,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02623309","title":"Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT03580655","title":"(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT02061761","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03983850","title":"Optimizing PTCy Dose and Timing","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":105,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00001873","title":"The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07172191","title":"Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases","has_results":false},{"nct_id":"NCT07524530","title":"Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":98,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03735992","title":"Mind-body Medicine for Patients With Malignant Hematological Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"Universität Duisburg-Essen","has_results":false},{"nct_id":"NCT06369662","title":"CD155 Expression in Acute Myeloid Leukemia","phase":"","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02223052","title":"Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06904066","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00957580","title":"Trial of Pimasertib in Hematological Malignancies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":81,"lead_sponsor_name":"EMD Serono","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}